Predicting outcomes for newly diagnosed metastatic breast cancer
Part of Cancer, Skin clinical trials.
This study uses information from women with newly diagnosed breast cancer that has spread (metastatic) to create a tool that helps predict how the disease may progress. By looking at your medical records, they hope to improve care and help future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a woman aged 18 or older
- You must have been recently diagnosed with invasive breast cancer
- Your case must be reviewed by the tumor board at the study site in Hungary between October 2018 and July 2025
- You cannot have had other cancers in the past (except bilateral breast cancer)
- You must plan to receive your primary treatment at the study site and have follow-up records for at least 12 months
- You must have had baseline staging (scans to check if cancer has spread)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what factors affect how long people with breast cancer that has spread to the brain live. It uses past medical records to find patterns that may help plan better care.
This study uses artificial intelligence to analyze tissue samples from breast cancer that has spread to distant organs, like the liver or lungs. The goal is to develop a tool that predicts how breast cancer might spread, helping doctors personalize treatment.
This study uses a computer program to look at blood test results from women treated for breast cancer. The goal is to see if patterns in inflammation markers can help predict outcomes.
This study looks for new lab “markers” that may help predict how breast cancer is likely to behave over time. Your tumor or health information may be used to find factors that can guide doctors’ predictions.
This trial looks at tumor cells in the blood of women with breast cancer to understand them better. It may help doctors learn more about how the disease spreads.
This trial tests if a special imaging analysis can predict where your cancer might spread. It's for people with advanced lung, colorectal, or breast cancer who are starting or continuing treatment.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.